Eli Lilly (LLY) EBT Margin (2009 - 2026)

Eli Lilly (LLY) has reported EBT Margin for 18 consecutive years, with 44.7% the latest figure, recorded in Q1 2026.

• EBT Margin for Q1 2026 came in at 44.7%, up 1755.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 43.08% (up 1533.0% YoY), and the FY2025 annual result was 39.48%, up 1133.0% from the prior year.
• EBT Margin was 44.7% for Q1 2026 at Eli Lilly, up from 42.85% in the prior quarter.
• Over five years, EBT Margin peaked at 44.7% in Q1 2026 and troughed at 4.5% in Q3 2023.
• Average EBT Margin over 5 years is 28.43%, with a median of 27.15% recorded in 2025.
• Year-over-year, EBT Margin slumped 1805 bps in 2023 and jumped 2721 bps in 2025.
• Over 5 years, EBT Margin stood at 28.71% in 2022, then decreased by 7 bps to 26.82% in 2023, then soared by 39 bps to 37.23% in 2024, then increased by 15 bps to 42.85% in 2025, then climbed by 4 bps to 44.7% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 44.7% in Q1 2026, 42.85% in Q4 2025, and 41.09% in Q3 2025.